Skip to main content
. 2016 Jun 10;14:31. doi: 10.1186/s12958-016-0164-y

Table 1.

Demographic Characteristicsa

Previous Treatment in Main Study
Total Group Ovaleap® Gonal-f®
Cycle 2 N = 147 N = 80 N = 67
 Age, years
  Mean (SD) 31.6 (3.3) 31.4 (3.4) 31.9 (3.0)
 Age, n (%)
   < 30 years 37 (25.2) 23 (28.8) 14 (20.9)
  30 to 34 years 77 (52.4) 42 (52.5) 35 (52.2)
   > 34 years 33 (22.4) 15 (18.8) 18 (26.9)
 Weight, kg
  Mean (SD) 63.2 (9.4) 63.1 (9.8) 63.4 (8.8)
 BMI, kg/m2
  Mean (SD) 22.7 (2.8) 22.7 (2.8) 22.6 (2.8)
 Smoker, n (%) 20 (13.6) 13 (16.3) 7 (10.4)
 Alcohol consumption, n (%) 25 (17.0) 18 (22.5) 7 (10.4)
Cycle 3 N = 61 N = 34 N = 27
 Age, years
  Mean (SD) 31.6 (3.2) 31.1 (3.5) 32.3 (2.8)
 Age, n (%)
   < 30 years 13 (21.3) 10 (29.4) 3 (11.1)
  30 to 34 years 34 (55.7) 19 (55.9) 15 (55.6)
   > 34 years 14 (23.0) 5 (14.7) 9 (33.3)
 Weight, kg
  Mean (SD) 63.5 (8.9) 62.5 (8.2) 64.7 (9.7)
 BMI, kg/m2
  Mean (SD) 23.0 (2.9) 22.8 (2.8) 23.3 (3.1)
 Smoker, n (%) 11 (18.0) 7 (20.6) 4 (14.8)
 Alcohol consumption, n (%) 13 (21.3) 8 (23.5) 5 (18.5)

BMI body mass index; SD standard deviation

aReasons for and duration of infertility were comparable between the Ovaleap® and Gonal-f® groups in the Main Study [9]